BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has a...
Evolving operating conditions across the Middle East are adding complexity to global supply chains, increasing the need for agility and preparedness across the logistics sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429645935/en/As Market Conditions Shift, FedEx Helps Businesses Keep Goods Moving (Photo: AETOSWire) As global and regional dynamics shift, key trade lanes are experiencing tighter capacity. Recent data shows...
IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2026 to shareholders of record as of June 18, 2026. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delightin...
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the o...
Estithmar Holding Q.P.S.C. announced its financial results for the first quarter of 2026, reporting a net profit of QAR 333 million, marking a significant 97% increase compared to the same period last year. The results underscore the strength of the Company’s operating model and the successful execution of its expansion strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429718889/en/Estithmar Holding Reports 97% Surge YoY i...
As part of an ongoing joint effort between the academic and commercial sectors, stemming from a Collaboration Agreement between the Autonomous University of Sinaloa (UAS) and Pacifico Mexinol (a subsidiary of Transition Industries) signed in 2024, UAS released the findings of the economic effects study of the world's largest ultra-low-carbon methanol plant, located near Topolobampo, Ahome, Sinaloa. The Pacifico Mexinol project is aligned with the UN Sustainable Development Goals by promoting ...
SouthernCrossAI (SCX), Australia's full-stack sovereign AI infrastructure company, today announced it is now providing sovereign AI inferencing capacity to the Equinix Fabric AI ecosystem, making its ASIC-powered inference nodes discoverable and accessible to enterprises, government agencies, and developers across the Equinix ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428587163/en/SCX brings sovereign AI to the Equ...
Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as "ATLATL"), global innovation platform for life science research and development, today announced that the companies have entered into a Memorandum of Understanding (MoU) on an open innovation program to accelerate early-stage biotech innovation in Asia-Pacific. Through this partnership, Samsung Bioepis aims to leverage ATLATL’s innovative R&D network and expertise in the Asia-Pacific biotech sector to ident...
Ion Exchange (India) Ltd, a leading provider of total water and environment management solutions globally, and MANN+HUMMEL, a world leader in filtration technology and intelligent separation solutions, have announced a strategic technology transfer and manufacturing collaboration for the production of advanced PVDF Ultrafiltration (UF) membranes with integrated UltraSKID systems, and subsequently a strategic technology transfer of Membrane Bio Reactor (MBR) solutions to India. This press relea...
Headline of release dated April 27, 2026 should read: Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival The updated release reads: YOSHIHIRO SHIMAMURA, A LEADING INVESTOR IN JAPAN’S ENTERTAINMENT INDUSTRY, TO HOST WORKSHOP AT THE 2026 CANNES FILM FESTIVAL Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a wor...